Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding
Christopher D. Cox, Georgia B. McGaughey, Michael J. Bogusky, et al.
Bioorganic & Medicinal Chemistry Letters (2009) Vol. 19, Iss. 11, pp. 2997-3001
Closed Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Conformational Searching with Quantum Mechanics
Matthew Habgood, Tim James, Alexander Heifetz
Methods in molecular biology (2020), pp. 207-229
Closed Access | Times Cited: 22
Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat
Paul J. Coleman, John D. Schreier, Anthony J. Roecker, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 14, pp. 4201-4205
Closed Access | Times Cited: 27
Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors
Changning Wang, Christian K. Moseley, Stephen M. Carlin, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 11, pp. 3389-3392
Open Access | Times Cited: 25
Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist
Ryo Suzuki, Dai Nozawa, Aya Futamura, et al.
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 6, pp. 1260-1275
Closed Access | Times Cited: 20
Discovery of HTL6641, a dual orexin receptor antagonist with differentiated pharmacodynamic properties
J.A. Christopher, Sarah J. Aves, Jason Brown, et al.
MedChemComm (2015) Vol. 6, Iss. 5, pp. 947-955
Closed Access | Times Cited: 17
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach
Bibia Heidmann, John Gatfield, Catherine Roch, et al.
ChemMedChem (2016) Vol. 11, Iss. 19, pp. 2132-2146
Closed Access | Times Cited: 17
A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging
Ping Bai, Sha Bai, Michael S. Placzek, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1018-1018
Open Access | Times Cited: 15
Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia
Aya Futamura, Ryo Suzuki, Yunoshin Tamura, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 13, pp. 115489-115489
Closed Access | Times Cited: 15
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists
Paul J. Coleman, John D. Schreier, Georgia B. McGaughey, et al.
Bioorganic & Medicinal Chemistry Letters (2010) Vol. 20, Iss. 7, pp. 2311-2315
Closed Access | Times Cited: 18
Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs
Georgia B. McGaughey, Christopher I. Bayly, Christopher D. Cox, et al.
Journal of Computer-Aided Molecular Design (2014) Vol. 28, Iss. 1, pp. 5-12
Open Access | Times Cited: 14
The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development Efforts
Jason M. Uslaner, W. Joseph Herring, Paul J. Coleman
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 1, pp. 161-168
Open Access | Times Cited: 13
Identification of highly selective and potent orexin receptor 1 antagonists derived from a dual orexin receptor 1/2 antagonist based on the structural framework of pyrazoylethylbenzamide
Aya Futamura, Dai Nozawa, Yuko Araki, et al.
Bioorganic & Medicinal Chemistry (2017) Vol. 25, Iss. 20, pp. 5203-5215
Closed Access | Times Cited: 12
Porous Polyrotaxane Coordination Networks Containing Two Distinct Conformers of a Discontinuously Flexible Ligand
Chris S. Hawes, Gregory P. Knowles, Alan L. Chaffee, et al.
Inorganic Chemistry (2016) Vol. 55, Iss. 20, pp. 10467-10474
Closed Access | Times Cited: 11
Formation of Bulky DNA Adducts by Non-Enzymatic Production of 1,2-Naphthoquinone-Epoxide from 1,2-Naphthoquinone under Physiological Conditions
Takuya Matsui, Naohito Yamada, Hideyuki Kuno, et al.
Chemical Research in Toxicology (2019) Vol. 32, Iss. 9, pp. 1760-1771
Closed Access | Times Cited: 11
Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor
Jakub Gunera, Jillian G. Baker, Niek van Hilten, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 19, pp. 11045-11053
Open Access | Times Cited: 10
Seven-membered rings
Adam G. Meyer, Alex C. Bissember, Christopher J. T. Hyland, et al.
Progress in heterocyclic chemistry (2021), pp. 565-614
Closed Access | Times Cited: 9
Seven-Membered Rings
Jason A. Smith, Peter P. Molesworth, Christopher J. T. Hyland, et al.
Progress in heterocyclic chemistry (2010), pp. 491-536
Closed Access | Times Cited: 8
Discovery and Chemical Development of Suvorexant - A Dual Orexin Antagonist for Sleep Disorder
Debra J. Wallace, Ian Mangion, Paul J. Coleman
ACS symposium series (2016), pp. 1-36
Closed Access | Times Cited: 7
Design and Synthesis of Conformationally Constrained RORγt Inverse Agonists
Ayumu Sato, Yoshiyuki Fukase, Mitsunori Kono, et al.
ChemMedChem (2019) Vol. 14, Iss. 22, pp. 1917-1932
Closed Access | Times Cited: 7
Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793
Cathy Préville, Pascal Bonaventure, Tatiana Koudriakova, et al.
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 10, pp. 2002-2009
Open Access | Times Cited: 7
The Human Orexin/Hypocretin Receptor Crystal Structures
Jie Yin, Daniel M. Rosenbaum
Current topics in behavioral neurosciences (2016), pp. 1-15
Open Access | Times Cited: 6
Synthesis, characterization, and X-ray analysis of new N,N′-disubstituted-1,4-diazepanes
Pedro I. Ramírez-Montes, María Eugenia Ochoa, Vianey Rodríguez, et al.
Tetrahedron Letters (2012) Vol. 53, Iss. 44, pp. 5887-5890
Closed Access | Times Cited: 5
Olefin Ring‐Closing Metathesis
Larry Yet
Organic reactions (2016), pp. 1-1304
Closed Access | Times Cited: 4
Computational studies on horseshoe shape pocket of human orexin receptor type 2 and boat conformation of suvorexant by molecular dynamics simulations
Qifeng Bai, Horacio Pérez‐Sánchez, Zhuoyu Shi, et al.
Chemical Biology & Drug Design (2018) Vol. 92, Iss. 1, pp. 1221-1231
Closed Access | Times Cited: 5
Molecular modeling technology studies of novel pyrazoylethylbenzamide derivatives as selective orexin receptor 1 antagonists
Qunlin Li, Cuihua Zhang, Yujie Ren
Journal of the Taiwan Institute of Chemical Engineers (2019) Vol. 100, pp. 1-17
Closed Access | Times Cited: 5

Scroll to top